These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 9547588)
1. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on eicosanoid concentrations in rat liver. Wilson MW; Leung LK; Hong JT; Glauert HP Adv Exp Med Biol; 1997; 400A():439-45. PubMed ID: 9547588 [No Abstract] [Full Text] [Related]
2. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators. Glauert HP; Hong JT; Leung LK; Wilson MW Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604 [No Abstract] [Full Text] [Related]
3. Altered hepatic eicosanoid concentrations in rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Wilson MW; Lay LT; Chow CK; Tai HH; Robertson LW; Glauert HP Arch Toxicol; 1995; 69(7):491-7. PubMed ID: 8526745 [TBL] [Abstract][Full Text] [Related]
4. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate. Leung LK; Glauert HP Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126 [TBL] [Abstract][Full Text] [Related]
5. Effects of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cellular antioxidants and lipid peroxidation in rats. Glauert HP; Srinivasan S; Tatum VL; Chen LC; Saxon DM; Lay LT; Borges T; Baker M; Chen LH; Robertson LW Biochem Pharmacol; 1992 Mar; 43(6):1353-9. PubMed ID: 1562286 [TBL] [Abstract][Full Text] [Related]
6. Effect of the peroxisome proliferators ciprofibrate and perfluorodecanoic acid on hepatic cell proliferation and toxicity in Sprague-Dawley rats. Chen H; Huang CY; Wilson MW; Lay LT; Robertson LW; Chow CK; Glauert HP Carcinogenesis; 1994 Dec; 15(12):2847-50. PubMed ID: 8001245 [TBL] [Abstract][Full Text] [Related]
7. Coordinate induction of acyl-CoA binding protein, fatty acid binding protein and peroxisomal beta-oxidation by peroxisome proliferators. Vanden Heuvel JP; Sterchele PF; Nesbit DJ; Peterson RE Biochim Biophys Acta; 1993 Jun; 1177(2):183-90. PubMed ID: 8499488 [TBL] [Abstract][Full Text] [Related]
8. Increased 8-hydroxydeoxyguanosine in hepatic DNA of rats treated with the peroxisome proliferators ciprofibrate and perfluorodecanoic acid. Huang CY; Wilson MW; Lay LT; Chow CK; Robertson LW; Glauert HP Cancer Lett; 1994 Dec; 87(2):223-8. PubMed ID: 7812944 [TBL] [Abstract][Full Text] [Related]
9. Effects of the peroxisome proliferator ciprofibrate and prostaglandin F2 alpha combination treatment on second messengers in cultured rat hepatocytes. Hong JT; Yun YP Arch Pharm Res; 1998 Apr; 21(2):120-7. PubMed ID: 9875418 [TBL] [Abstract][Full Text] [Related]
10. Comitogenicity of eicosanoids and the peroxisome proliferator ciprofibrate in cultured rat hepatocytes. Hong JT; Glauert HP J Cell Physiol; 1996 Nov; 169(2):309-19. PubMed ID: 8908198 [TBL] [Abstract][Full Text] [Related]
11. Effect of phenobarbital and the peroxisome proliferator ciprofibrate on gamma-Glutamyltranspeptidase activity and leukotriene C4 concentration in cultured rat hepatocytes. Hong JT; Wilson MW; Glauert HP J Biochem Toxicol; 1995 Oct; 10(5):239-243. PubMed ID: 8847705 [TBL] [Abstract][Full Text] [Related]
12. Treatment of rats with the peroxisome proliferator ciprofibrate results in increased liver NF-kappaB activity. Li Y; Leung LK; Glauert HP; Spear BT Carcinogenesis; 1996 Nov; 17(11):2305-9. PubMed ID: 8968042 [TBL] [Abstract][Full Text] [Related]
13. Comparative hypolipidaemic and peroxisomal effects of ciprofibrate, clofibric acid, and their respective difluorocyclopropyl and 4-fluoro-substituted analogues in rat. Graham MJ; Winham MA; Old SL; Gray TJ Xenobiotica; 1996 Jul; 26(7):695-707. PubMed ID: 8819300 [TBL] [Abstract][Full Text] [Related]
14. Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats. Leung LK; Glauert HP Toxicology; 1998 Feb; 126(1):65-73. PubMed ID: 9585093 [TBL] [Abstract][Full Text] [Related]
15. Lack of correlation between hepatic prostaglandin concentrations and DNA synthesis after the administration of phenobarbital and the peroxisome proliferator ciprofibrate in rats. Leung LK; Glauert HP Toxicology; 1997 Nov; 123(1-2):101-9. PubMed ID: 9347925 [TBL] [Abstract][Full Text] [Related]
16. Influence of peroxisome proliferators on phosphoprotein levels in human and rat hepatic-derived cell lines. Passilly P; Jannin B; Latruffe N Eur J Biochem; 1995 May; 230(1):316-21. PubMed ID: 7601116 [TBL] [Abstract][Full Text] [Related]
17. Effect of dexamethasone on ciprofibrate-induced cell proliferation and peroxisome proliferation. Rao MS; Subbarao V Fundam Appl Toxicol; 1997 Jan; 35(1):78-83. PubMed ID: 9024675 [TBL] [Abstract][Full Text] [Related]
18. Ciprofibrate, a carcinogenic peroxisome proliferator, increases the phosphorylation of epidermal-growth-factor receptor in isolated rat hepatocytes. Orellana A; Holuigue L; Hidalgo PC; Faúndez V; González A; Bronfman M Eur J Biochem; 1993 Aug; 215(3):903-6. PubMed ID: 8354295 [TBL] [Abstract][Full Text] [Related]
19. Comparative and simultaneous effects of simvastatin and ciprofibrate on plasma lipid parameters and upon hepatic drug metabolizing and peroxisome proliferation marker enzymes in the male Wistar rat. Charmoillaux M; Goudonnet H; Mercenne F; Mounié J; Truchot RC Cell Mol Biol; 1991; 37(8):765-71. PubMed ID: 1807786 [TBL] [Abstract][Full Text] [Related]
20. Effect of ciprofibrate, bezafibrate, and LY171883 on peroxisomal beta-oxidation in cultured rat, dog, and rhesus monkey hepatocytes. Foxworthy PS; White SL; Hoover DM; Eacho PI Toxicol Appl Pharmacol; 1990 Jul; 104(3):386-94. PubMed ID: 1974728 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]